Inozyme Pharma Company Profile, Contacts & Intelligence

Biotechnology Research321 Summer St59 employeesFounded 2016
3 contacts with email or phone data3 with email data2 with phone data
View verified contacts Compare competitors
Employees
59
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
5
Mapped contact coverage

Inozyme Pharma Overview

We are a pioneering, clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. Our lead candidate, INZ-701, is an ENPP1 Fc fusion protein enzyme replacement therapy (ERT) designed to increase PPi and adenosine, enabling the potential treatment of multiple diseases caused by deficiencies in these metabolites. By targeting the PPi-Adenosine Pathway, INZ-701 aims to correct pathological mineralization and intimal proliferation, addressing the significant morbidity and mortality in these devastating diseases. It is currently in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis.

Headquarters
321 Summer St
Website
inozyme.com
Industry
Biotechnology Research
Founded
2016
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
(CMS) of a new set of ICD-10 diagnosis codes to support the classification of disorders of pyrophosphate metabolism

Inozyme Pharma Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 2 with phone data in the visible sample.
5 departments represented
Visible contacts with email or phone data are mapped to these departments.
6 company-domain emails
Visible contacts using Inozyme Pharma's company email domain.
General
5
Healthcare
4
Finance
1
Legal
1
Executive
1

Inozyme Pharma People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

L
Lynne Sullivan
Chief Financial Officer at Unity
EP
Y
Yves Sabbagh, Phd
Chief Scientific Officer at Inozyme
E
H
Herve Husson
C
Christian Phillips
Senior Vice President, Cmc
EP

Inozyme Pharma Workforce Composition

Seniority breakdown across 17 visible profiles.

Senior / Lead
4
Executive
3
Director
3
Manager
3
Individual contributor
2
VP / Head
1
Associate / junior
1

Compare Similar Companies to Inozyme Pharma

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
BioMarin Pharmaceutical Inc. Biotechnology Research 3.12K View company
Alnylam Pharmaceuticals Biotechnology Research 2.58K View company
Harmony Biosciences Pharmaceutical Manufacturing 318 View company
Abeona Therapeutics Biotechnology Research 192 View company
Soleno Therapeutics, Inc. Pharmaceutical Manufacturing 130 View company
Astria Therapeutics, Inc. Biotechnology Research 118 View company
Rezolute, Inc. Biotechnology Research 75 View company
Fulcrum Therapeutics Biotechnology Research 71 View company
Zevra Therapeutics Biotechnology Research 64 View company
Stealth BioTherapeutics Biotechnology 58 View company